Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C	Roche	Ongoing	Pegasys	4	MV25599	King Abdullah Medical City (Makkah), King Faisal Specialist Hospital and Research Center (Riyadh), Prince Sultan Military Medical City (Riyadh)
A Prospective Multicentre Randomised Controlled Trial of Early Goal Directed Sedation Compared with Standard Care in Mechanically Ventilated Patients in Intensive Care	Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG)	Ongoing	Dexmedetomidine	4	RC 12-079	King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)
A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)	Novartis	Ongoing	Everolimus	4	CRAD001A2433	Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
Prevalence and Patient Experience with Condylomas Study in Saudi Arabia	Merck Serono	Ongoing	N/A	4	PREPEC	King Abdulaziz University Hospital (Jeddah), Prince Sultan Military Medical City (Riyadh) , King Fahad Medical City (Riyadh)
Global Registry Program on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation.	Boehringer Ingelheim	Ongoing	Dabigatran (dabigatran etexilate = prodrug)	4	1160.129	King Fahad Medical City (Riyadh), King Faisal Hospital (Taif) , King Salman Bin AbdulAziz Hospital (Riyadh), King Fahad Hospital (Hofuf), Armed Forces Hospital (Southern Region) , Armed Forces Hospital (North West Region)
Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial)	King Faisal Specialist Hospital & Research Centere	Ongoing	PLASMA DERIVED Factor VIII Recombinant FVIII	4	ABB- 09 -001	King Faisal Specialist Hospital and Research Center (Riyadh)
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study	Eli Lilly	Ongoing	N/A	4	F3Z-MC-B010	Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Taif) , King Fahad Medical City (Riyadh)
An international, multicenter, observational study to compare real life VTE prophylaxis, during hospital stay, in cancer patients undergoing major abdominal or pelvic surgery versus international guidelines (ACCP 2008).	Sanofi	Ongoing	N/A	4	DIREG_R_04917	King Faisal Specialist Hospital and Research Center (Jeddah)
Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi	Sanofi	Ongoing	Lantus®	4	LANTUL06939	King Fahd Military Medical Complex (Dhahran), Armed Forces Hospital (Southern Region), Polyclinics in western province
Disease pattern in patient with acute respiratory tract infections in Saudi Arabia	Sanofi	Ongoing	N/A	4	DIREG_L_05605	Erfan & Bagedo General Hospital (Jeddah)